Basic fibroblast growth factor (bFGF) and epi dermal growth factor (EGF) are neuroprotective during anoxia and nitric oxide (NO) toxicity. Signal transduction systems that modulate protein kinase C (PKC) also can modulate the toxic effects of anoxia and NO. We there fore examined whether PKC was involved in the protec tive effects of bFGF and EGF during anoxia and NO toxicity. Down-regulation or inhibition of PKC activity before anoxia or NO exposure prevented hippocampal neuronal degeneration. Yet, this protective effect of inhi bition of PKC activity was not present with the coadmin istration of growth factors. Combined inhibition of PKC activity and application of bFGF or EGF lessened the protective mechanisms of the growth factors. In addition, the protective ability of the growth factors was lost during anoxia and NO exposure with the activation of PKC, Peptide growth factors are increasingly being linked to the neurodegenerative effects of cerebral ischemia. In animal models, increased expression of basic fibroblast growth factor (bFGF) has been documented during both focal (Kumon et aI., 1993) and global (Takami et aI., 1992) models of cerebral ischemia. Administration of some trophic factors, such as insulin-like growth factor (Guan et aI., 1993) and transforming growth factor-Bl (Gross et aI., 1993), can reduce or limit the extent of cerebral
suggesting that at least a minimal degree of PKC activa tion is necessary for growth factor protection. Although modulation of PKC activity may be a necessary prereq uisite for protection against anoxia and NO toxicity by bFGF and EGP, only inhibition of PKC activity, rather than application of the growth factors, was protective fol lowing exposure to NO. These results suggest that the mechanism of protection by bFGF and EGF during an oxia and NO toxicity appears initially to be dependent on a minimum degree of PKC activation, but that other sig nal transduction pathways independent of PKC also may mediate protection by peptide growth factors. Key Words: Basic fibroblast growth factor-Cellular signal transduc tion-Cerebral ischemia-Epidermal growth factor Hippocampal neurons-Sodium nitroprusside. infarction in vivo. In fact, mice expressing a bFGF transgene demonstrate increased resistance to hyp oxic-ischemic cerebral damage (MacMillan et aI., 1993) . Trophic factors also have been shown to pre vent neurodegeneration in hippocampal cultures during glutamate toxicity (Mattson et aI., 1989) , po tassium cyanide (KCN) administration (Pauwels et ai., 1989) , hypoglycemia (Cheng and Mattson, 1991) , and nitric oxide (NO) toxicity (Maiese et aI., 1993a) . Of the growth factors, bFGF and epidermal growth factor (EGF) are of significant interest be cause they are present throughout the brain and are protective during ischemia (Pauwels et aI., 1989; Kinoshita et aI., 1990; Yamada et aI., 1991; Freese et aI., 1992) .
NO, a free radical, also influences neuronal sur vival during ischemic cell death. Glutamate release during anoxia leads to both calcium influx into neu rons and the production of NO (Garthwaite et aI., 1989; Maiese et al., 1994b) . Inhibition of NO produc tion in cell culture systems during glutamate toxic-ity (Dawson et al., 1991) or during anoxia (Maiese et al., 1993a,b; Maise et al., 1994b) is neuroprotective. During global cerebral ischemia, production of NO is increased (Tominaga et al., 1993) and nitric oxide synthase (NOS) is induced in hippocampal astro cytes (Endoh et al., 1993) . Although controversial, NO may mediate neuronal cell death during in vivo models of cerebral ischemia. Blockade of NO for mation by some NOS inhibitors can reduce infarc tion following middle cerebral artery occlusion (Buisson et al., 1992; Nagafuji et al., 1992) .
In addition to the trophic factors and NO, other signal transduction pathways can influence neuronal survival. For example, protein kinase C (PKC) can alter the toxic effects of both anoxia and NO. During cerebral ischemia, increased levels of PKC are present in the hippocampal CAl region (Cardell et al., 1990; Hara et al., 1990) and PKC activity can regulate the release of glu tamate (Lu et al., 1993) , suggesting that PKC activation may lead to ischemic neuronal dam age. During periods of global ischemia, agents that decrease PKC activity can prevent neuronal damage (Hara et al., 1990) . In vitro experiments have linked PKC with both excitatory amino acid and NO toxicity. Inhibition of PKC activity has been shown to reduce neuronal death during peri ods of glutamate and kainate toxicity (Favaron et al., 1988) . In addition, we have recently demon strated that inhibition of PKC activity is protective against both anoxia and NO exposure in primary hippocampal neuronal cultures (Maiese et al., 1993b,c) .
It appears that multiple mechanisms, rather than a single cellular pathway, determine neuronal sur vival during an ischemic insult. Because trophic factors protect against both anoxia and NO, and PKC is known to influence neuronal survival under these same conditions, it is conceivable that the neuroprotective effects of growth factors are depen dent upon the PKC pathway. PKC mediates the migratory (Joyce and Meklir, 1992) and trophic re sponses (Abe et al., 1992) of EGF. In addition, bFGF has been shown to activate PKC (Oury et al., 1992) and be dependent on PKC activity (Presta et al., 1991) for cell proliferation. Therefore, we examined whether the protective effects of the trophic factors bFGF and EGF were linked to the regulation of PKC activity. We demonstrate that the mechanism of protection by these growth fac tors during anoxia and NO toxicity appears to re quire a minimum level of PKC activation, but that other signal transduction pathways independent of PKC also may mediate protection by bFGF and EGF.
METHODS

Hippocampal neuronal cultures
The hippocampi were obtained from I-day-old Spra gue-Dawley rat pups and maintained by a method modi fied from Furshpan and Potter (1989) . Hippocampal sec tions were then incubated in dissociation medium con taining papain (10 U/ml) and cysteine (3 mmol/L) for two 20-min periods. The hippocampi were rinsed in dissocia tion medium and incubated in dissociation medium con taining trypsin inhibitor (10-20) U/ml) three times, 5 min each. The cells were washed in growth medium three times, 2 min each, and triturated 50 times in 2 ml of growth medium. The trituration was repeated five times with fresh growth medium to yield a total of 10 ml of cell suspension. Forty milliliters of Opti-MEM-I (Gibco BRL, Gaithersburg, MD, U. S. A. ) were added to this cell sus pension and the dissociated cells were plated at a density of � 1. 5 x 105 cells/mm 2 in 35 mm 2 polylysine-Iaminin coated plates (Falcon Labware, Lincoln Park, NJ, U. S.A.). Cells were maintained in growth medium at 37°C in a humidified atmosphere of 5% CO2 and 95% room air. Following a 2-h incubation period to allow for cell adhe sion, culture' medium was replaced with 1.5 ml of growth medium, which was subsequently replaced weekly. All experiments were performed with neurons that had been in culture for 2-3 weeks. Nonneuronal cells, which were identified by morphology, accounted for <20% of the to tal cell population. Dissociation medium contained 90 mMNa2S04' 30 mM K2S04, 5. 8 mM MgCI2, 0.25 mM CaCI2, 10 mM kynurenic acid, and 1 mM HEPES with pH adjusted to 7. 4. Growth medium consisted of Leibovitz's L-15 Me dium (Gibco BRL) with 6% sterile rat serum (Bioproducts for Science, In dianapolis, IN, U. S. A. ), 150 mM NaHC03, 2. 25 mg/ml transferrin, 2. 5 t-Lg/ml insulin, 10 nM progesterone, 90 t-LM putrescine, 15 nM selenium, 35 mM glucose, 1 mM L-glutamine, penicillin (50 U/ml) , streptomycin (50 t-Lg/ml) , and vitamin mix. The vitamin mix contained L-proline (0. 2 M), L-cysteine (0.025 M), p-aminobenzoic acid (7. 0 mM), vitamin B\2 (0.3 mM), inositol (II mM), choline chloride (14.0 mM), fumaric acid (0. 04 M), coenzyme A (0. 1 mM), d-biotin (8 t-LM), and DL-6,8-thiotic acid (0. 5 mM).
Experimental treatments
Cultures were deprived of oxygen by placing them in a humidified atmosphere at 37°C with 95% N2 and 5% CO2 for an 8-h period. NO administration was performed by replacing the culture media with media containing 300 t-LM sodium nitroprusside (SNP) (Sigma Chemical Company, St. Louis, MO, U.S.A.) for 5-10 min. At this dose of SNP, � 70-80% of the neurons are killed by a mechanism that involves generation of NO (Maiese et al., I993a) . Following treatment with oxygen deprivation or NO, cul ture medium was replaced with fresh growth medium and the cultures were placed in a normoxic, humidified incu bator at 37°C with 5% CO2 for 24 h before assessing cell death.
The pharmacologic agents phorbol-12-myristate-13acetate (PMA) and 4-phorbol-12,13-didecanoate (PDD) were obtained from Sigma Chemical Company. The drugs H-7 and H-8 were purchased from Calbiochem Company (La Jolla, CA, U. S. A. ). All agents were added directly to the cultures I h before anoxia or NO administration with the exception of PMA (1 t-LM) and PDD (1 t-LM), which required 24-h pretreatment prior to anoxia or NO admin istration. The growth factors bFGF (recombinant human bFGF) and EGF (recombinant human EGF) were ob tained from R&D Systems, Minneapolis, MN, U.S.A. The growth factors were prepared as stock solutions and diluted directly to the cultures 24-h before anoxia or NO administration. Experimental cultures involving the use of H-7, H-8, bFGF, or EGF received replacement of these agents during any growth medium changes.
Assessment of neuronal cell death
Hippocampal neuronal injury was determined by bright field microscopy using a 0.4% try pan blue dye exclusion method 24 h following oxygen deprivation or treatment with NO. Neurons were identified by morphology. The mean survival was determined by counting eight ran domly selected nonoverlapping fields, with each contain ing -10-20 neurons (viable + nonviable) in each 35-mm Petri dish. The mean survival from each culture dish rep resents an n = 1 determination. Each experiment was replicated 3-6 times independently on separate occasions with different cultures.
RESULTS
Basic FGF and EGF are neuroprotective during anoxia and NO exposure
We have previously demonstrated that bFGF and EGF are protective during anoxia and NO toxicity (Maiese et aI., 1993a) . Yet, in the current study, it is imperative that the protective abilities of bFGF and EGF be demonstrated with the present generation of primary hippocampal neuronal cultures. In this respect, any alterations in the protective abilities of the peptide growth factors during the pharmaco logic manipulation of PKC can be attributed to the modulation of PKC activity and not to variations in the physiologic response of our primary hippocam pal neuronal cultures to the growth factors, anoxia, or NO exposure. When hippocampal neurons were placed in an oxygen-free environment for 8-h in the absence of growth factors, �30% of hippocampal neurons survived. A 24-h pretreatment with bFGF 00 ng/m!) and EGF 00 ng/ml) increased hippocam pal neuronal survival to 68 ± 2 and 79 ± 3%, re spectively ( Fig. O . Administration of both bFGF and EGF protected �6 3% of the neurons. A 5-min exposure to SNP resulted in a neuronal survival of 25 ± 8%. Yet, similar to the degree of protection observed during anoxia, bFGF and EGF adminis tered 24 h before NO exposure increased neuronal survival to 70 ± 5% (bFGF) and to 77 ± 5% (EGF).
Combined treatment with the peptide growth fac tors raised neuronal survival to 60 ± 6% ( Fig. O .
Down-regulation of PKC activity reduces the protective capacity of the peptide growth factors
We next studied hippocampal neuronal survival under conditions of normoxia, anoxia, and NO tox· icity during chronic down-regulation of PKC and administration of the peptide growth factors. To chronically down-regulate and inhibit PKC activity, we pretreated cultures with PMA 0 JJ.M) 24 h be fore anoxia or SNP administration. A 20-h pretreat ment with PMA (1 JJ.M) down-regulates PKC activ ity in rat primary neuronal cultures (Matthies et aI., 1987) . Down-regulation of PKC activity was not detrimental to neuronal survival during normoxia and was protective during anoxia and NO exposure ( Fig. 2A) . In contrast, combined down-regulation of PKC activity and application of the trophic factors during anoxia decreased hippocampal neuronal sur vival. For example, neuronal survival was 68 ± 2% with bFGF and 79 ± 3% with EGF during anoxia but decreased to 49 ± 7% (bFGF) and 44 ± 5% (EGF) with PKC activity down-regulation. Survival Peptide growth factors are neuropro tective during anoxia and NO exposure. Hip pocampal cultures were pretreated with ei ther bFGF (10 ng/ml), EGF (10 ng/ml), or combined bFGF (10 ng/ml) and EGF (10 ng/ ml) treatment during normoxic conditions (gray bars) or 24 h before an 8-h period of anoxia (black bars) or a 5-min exposure of SNP (300 fLM) (hatched bars). Neuronal sur vival was based on the percentage of the to tal number of neurons (viable + nonviable) and determined by trypan blue exclusion 24 h following exposure to the growth factors (normoxia protocol) or following exposure to anoxia or SNP. Each datum point represents the mean and standard deviation of n = 10 determinations (culture plates) from six sep arate experimental preparations. Control cultures received no growth factors and were exposed to normoxia, anoxia, or SNP (300 fLM). Results of neuronal survival be tween groups 1 and 2 during anoxia or NO generation are statistically different using the unpaired Student's t test with p < 0.001. Hippocampal neuronal cultures received a chronic 24-h pre treatment with PMA (1 fJ-M) (cPMA), POD (1 fJ-M), or PMA (1 j.LM) (cPMA) with bFGF (10 ng/ml), EGF (10 ng/ml). or com bined bFGF (10 ng/ml) and EGF (10 ng/ml) treatment during normoxia or before an 8-h period of anoxia or a 5-min expo sure of SNP (300 fJ-M). Results of neuronal survival between groups 1, 2, and 3 during anoxia or NO generation are sta tistically different using the unpaired Student's t test with p < 0.001. B: Hippocampal neuronal cultures received a 1-h pre treatment with H-7 (10 fJ-M) alone, or H-7 (10 fJ-M) with bFGF (10 ng/ml), EGF (10 ng/ml). or combined bFGF (10 ng/ml) and EGF (10 ng/ml) during normoxia or before an 8-h period of anoxia or a 5-min exposure of SNP (300 fJ-M). Results of neu ronal survival between groups 1, 2, and 3 during anoxia or NO generation are statistically different using the unpaired Stu dent's t test with p < 0.001. Of note, neuronal survival with the treatment of H-7 and bFGF during anoxia (group 3) did not reach statistical significance of p < 0.001 when compared with group 1. C: Hippocampal neuronal cultures received a 1-h pretreatment with H-8 (10 fJ-M) alone, or H-8 (10 fJ-M) with bFGF (10 ng/ml), EGF (10 ng/ml), or combined bFGF (10 ng/ ml) and EGF (10 ng/ml) during normoxia or before an 8-h pe riod of anoxia or a 5-min exposure of SNP (300 fJ-M). Results of neuronal survival between groups 1, 2, and 3 during an oxia or NO generation are statistically different using the un paired Student's t test with p < 0.001. Of note, neuronal sur vival with the treatment of H-8 and combined bFGF and EGF during anoxia (group 3) did not reach statistical significance of p < 0.001 when compared with group 2. (A), (8), and (C), control cultures received no growth factors and were exposed to normoxia (gray bars), anoxia (solid bars), or SNP (300 fJ-M) (hatched bars). Neuronal survival was based on percentage of the total number of neurons (viable + nonviable) and de-with combined bFGF and EGF treatment during down-regulation of PKC activity also was reduced from 60 ± 6% to 50 ± 6%. Treatment with PDD (1 fLM), an inactive phorbol ester derivative, did not alter the protective effects of the trophic factors ( Fig. 2A ). Survival with PDD during anoxia was 70 ± 7% with bFGF and 81 ± 5% with EGF. This supports the hypothesis that the effect of PMA (1 fLM) was due to the down-regulation of PKC activ ity.
The peptide growth factors also were less protec tive with the down-regulation of PKC activity dur ing exposure to SNP. Combined down-regulation of PKC activity and application of the growth factors during treatment with SNP decreased neuronal sur vival from 68 ± 2% with bFGF and from 79 ± 3% with EGF ( Fig. l) to 50 ± 6% (bFGF) and to 58 ± 7% (EGF) ( Fig. 2A ). Treatment with both bFGF and EGF during down-regulation of PKC activity also decreased neuronal survival from 60 ± 6% (Fig. I) to 55 ± 5% ( Fig. 2A) . Neuronal survival did not differ from control cultures receiving only SNP during the coapplication of PDD and the peptide growth factors ( Fig. 2A) .
Neuroprotection by peptide growth factors is reduced by pharmacologic inhibition of
PKC activity
In addition to evaluating the effects of chronic down-regulation of PKC activity on growth factor protection, we also examined the role of inhibition of PKC activity during growth factor administra tion. The agents H-7 and H-8 have broad biologic applicability with in vitro and in vivo systems to inhibit PKC-induced phosphorylation (Hidaka and Kobayashi, 1992) . H-7 and H-8 are permeable to cells and directly inhibit the activity of PKC (Hidaka et aI., 1984) . During either anoxia or expo sure to NO, inhibition of PKC activity with to fLM of the agent H-7 (K; = 6.0 fLM) ( Fig. 2B ) or with 10 fLM of the agent H-8 (K; = 15.0 fLM) (Fig. 2C ) in creased survival from -30 to -80%. Administra tion of H-7 or H-8 was not detrimental to the hip pocampal neurons during normoxic conditions (Fig.  2B,C) .
Yet, this degree of protection was not present with the combined treatment of H-7 or H-8 and the peptide growth factors during anoxia or SNP. Inhi bition of PKC activity with H-7 during anoxia retermined by trypan blue exclusion 24 h following exposure to the growth factors (normoxia protocol) or following expo sure to anoxia or SNP. Each datum point represents the mean and standard deviation of n = 8 determinations (cul ture plates) from four separate experimental preparations. sulted in a neuronal survival of 35 ± 6 and 47 ± 5% with the administration of bFGF and EGF, respec tively (Fig. 2B) . A partial loss in protection by the peptide growth factors also was observed during inhibition of PKC activity during anoxia with H-8. Treatment with H-8 and the growth factors reduced neuronal survival from 78 ± 5% with only H-8 ad ministration to 49 ± 7% with bFGF and to 44 ± 5% with EGF (Fig. 2C) . Interestingly, combined admin istration of bFGF and EGF with either H-7 or H-8 during anoxia reduced survival to a lesser degree than individual treatment with the growth factors and inhibition of PKC activity. For example, neu ronal survival with administration of both growth factors and H-7 was 60 ± 5% ( Fig. 2B) and with H-8 was 63 ± 6% (Fig. 2C ). This may suggest that when the growth factors are present together, either bFGF or EGF may be capable of sufficiently con trolling PKC activity to confer protection during an anoxic insult.
Administration of either H -7 or H -8 in combina tion with the growth factors also reduced the pro tective capacity of bFGF and EGF during NO ex posure (Fig. 2B,C) . PKC inhibition with H-7 alone during SNP administration increased neuronal sur vival from 25 ± 7 to 77 ± 7%. In contrast, treatment with H-7 decreased neuronal survival to 62 ± 6, 61 ± 6, and 55 ± 7% with the administration of bFGF, EGF, and both growth factors, respectively (Fig.  2B) . A similar loss of protection was evident with H-8 treatment during growth factor administration. Treatment with H-8 alone during NO exposure in creased survival to -70%, but resulted in a neuro- nal survival of 53 ± 5% (bFGF), 55 ± 8% (EGF), and 50 ± 7% (bFGF and EGF) during the applica tion of the growth factors (Fig. 2C) . In contrast to our observations during anoxia, protection with the combined administration of the growth factors and either H-7 or H-8 during NO exposure was not sig nificantly different from the protection obtained with individual application of the growth factors and inhibition of PKC activity.
Activation of PKC eliminates the protective effects of the peptide growth factors
Both bFGF and EGF are known to activate PKC (Li et aI., 1991; Oury et aI., 1992) . Because the neu roprotective effects of peptide growth factors are reduced during down-regulation or inhibition of PKC activity, we examined whether activation of PKC activity would maintain or enhance growth factor protection. We activated PKC by pretreating the cultures with PMA (100 nM) during normoxia and 1 h before anoxia or exposure to NO. A I-h application of PM A (100 nM) is sufficient to activate PKC (Lai and EI-Fakahany, 1987) . During nor moxia, acute treatment with PMA (100 nM), which increases PKC activity,' decreased neuronal sur vival from 89 ± 6 to 30 ± 5% (Fig. 3) . Activation of PKC before anoxia or SNP administration did not significantly alter neuronal survival when compared with untreated anoxic cultures (28 ± 5%) or cul tures exposed to NO (25 ± 8%) ( Fig. 3) .
During anoxia and the activation of PKC, the pro tective effects of the growth factors were decreased to a greater degree than during trials with down- Activation of PKC during growth fac tor administration is toxic during anoxia or NO exposure. Hippocampal neuronal cul tures received an acute 1-h pretreatment with PMA (100 nM) (aPMA), bFGF (10 ng/ml), EGF (10 ng/ml), or PMA (100 nM) (aPMA) with bFGF (10 ng/ml), EGF (10 ng/ml), or combined bFGF (10 ng/ml) and EGF (10 ngl ml) treatment during normoxia or before an 8-h period of anoxia or a 5-min exposure of SNP (300 fLM). Results of neuronal survival between group 2 and groups 1 and 3 during anoxia or NO generation are statistically dif ferent using the unpaired Student's t test with p < 0.001. Control cultures received no growth factors and were exposed to nor moxia (gray bars), anoxia (solid bars), or SNP (300 fLM) (hatched bars). Neuronal survival was based on percentage of the total number of neurons (viable + nonviable) and deter mined by trypan blue exclusion 24 h follow ing exposure to the growth factors (nor moxia protocol) or following exposure to an oxia or SNP. Each datum pOint represents the mean and standard deviation of n = 8 determinations (culture plates) from four separate experimental preparations. regulation or inhibition of PKC activity. Addition of PMA (100 nM) with the application of the peptide growth factors decreased hippocampal neuronal survival for bFGF to 23 ± 4% and for EGF to 31 ± 6% (Fig. 3) . Neuronal survival with PKC activation and combined bFGF and EGF treatment was mod estly improved to 41 ± 5%, but this degree of pro tection was significantly less than the survival ob served with growth factor application and inhibition of PKC activity.
Similar to the results observed with anoxia, acti vation of PKC in combination with the administra tion of growth factors was not protective during NO toxicity. Although treatment with bFGF increased survival to 85 ± 4% and EGF increased survival to 82 ± 8% during NO exposure, activation of PKC in the presence of the growth factors decreased sur vival to 36 ± 2% (bFGF) and to 37 ± 8% (EGF) (Fig. 3) . Combined bFGF and EGF administration in the presence of PKC activation also was not pro tective during NO exposure and resulted in a sur vival of 33 ± 6%.
Thus, it appears that the growth factors bFGF and EGF are dependent upon the regulation of PKC activity for their protective effects. Yet, it is the degree of modulation of PKC activity that appears to be the significant factor. Down-regulation or in hibition of PKC activity compromises the capabili ties of these trophic agents and "excessive" stim ulation of PKC activity, such as with the application of PM A (100 nM), appears to completely negate the neuroprotective capacity of the growth factors. , bFGF (10 ng/ml), or EGF (10 ng/ml) at 4 h, 2 h, and 1 h before SNP (300 fLM) expo sure, and at the time of, 1 h, 2 h, 4 h, 6 h, 12 h, and 24 h following onset of SNP adminis tration. Neuronal survival was based on per centage of the total number of neurons (via ble + nonviable) and determined by the try pan blue exclusion method 24 h following exposure to SNP. In the absence of SNP, the percentage of viable cells was 88 ± 6%, whereas SNP reduced viability to 25 ± 8%. The values are the means and standard de viation of n = 6 determinations (culture plates) from three separate experimental preparations. Growth factors and PKC differ in the capacity to protect neurons following an insult from NO We have demonstrated that either treatment with the peptide growth factors bFGF and EGF (Maiese et aI., 1993a) or inhibition of PKC activity (Maiese et aI. , 1993b .c) before anoxia or NO toxicity is neu roprotective. In addition, modulation of PKC activ ity appears to regulate the protective ability of the growth factors. Yet, it is not known whether these protective alterations in the cellular signal transduc tion pathways by growth factors or PKC can re verse a previously sustained insult. To determine whether peptide growth factors or inhibition of PKC activity is neuroprotective postexposure to anoxia or NO, we administered bFGF (10 f.LM), EGF (10 fLM), H-7 (10 fLM), and H-8 (10 fLM) at 4 h, 2 h, and 1 h before SNP (300 fLM) exposure, and at the time of, 1 h, 2 h, 4 h, 6 h, 12 h, and 24 h following the onset of SNP administration.
Administration of bFGF at 4 h and 2 h before NO exposure increased neuronal survival from � 30 to 63 ± 4 and 60 ± 4%, respectively. Protection from NO toxicity was minimal with l-h pretreatment with a survival of 44 ± 4% and was essentially lost with the posttreatment regimens (Fig. 4) . Treatment with EGF essentially paralleled the results with bFGF. Neuronal survival was 57 ± 4 and 50 ± 8% with 4-h and 2-h EGF pretreatment. There was no significant neuronal protection with the later treat ment periods (Fig. 4) .
In contrast to the peptide growth factors, protec tion with inhibition of PKC activity by H -7 was Time of Treatment present with both pre-and posttreatment during NO toxicity. Neuronal survival remained �70% during the 4-h, 2-h, and I-h pretreatment times (Fig. 4) . Protection also was present with administration of H-7 at the time of SNP exposure and up to 4 h post-SNP treatment (Fig. 4) . No significant degree of protection was obtained with the posttreatment periods of 6, 12, and 24 h. A similar time course and degree of protection was observed with H-8 admin istration. Neuronal survival ranged from �62 to 67% during the 4-h, 2-h, and I-h pretreatment peri ods with H -8. A significant degree of protection also was maintained during the posttreatment protocols with the minimal survival maintained at 56 ± 4% at the 4-h posttreatment period. Neuronal protection against NO toxicity was lost with H-8 administra tion after the 4-h posttreatment period (Fig. 4) .
Although modulation of PKC activity may be a necessary prerequisite for protection against anoxia and NO toxicity by the peptide growth factors bFGF and EGF, it does not appear that the trophic factors are entirely dependent on the PKC pathway. In our primary hippocampal neuronal cell cultures, protection by bFGF and EGF is achieved only with treatment :;;,: 4 h prior to a NO insult. In contrast, inhibition of PKC activity can provide neuronal protection against NO exposure with pretreatment and with treatment :;;,: 4 h following SNP application. -This suggests that bFGF and EGF employ a mech anism of protection that is initially dependent on the PKC pathway, but that the trophic factors may then require other signal transduction pathways that are independent of PKC activity.
DISCUSSION
Following an ischemic insult, the cellular envi ronment in the central nervous system initially is influenced by the compromise of cerebral blood flow and metabolism. Subsequent selective phar macologic modulation of blood flow and metabo lism (Morikawa et al., 1992; Maiese et al., 1994) or specific neuronal networks (Maiese et al., 1992) can prevent neuronal degeneration. Yet, it is now clear that the modulation of cellular signal transduction pathways also can influence the extent of neuronal degeneration after injury. Inhibition of NO produc tion during anoxia (Maiese et al., 1993a,b; Maiese et al., 1994b) or glutamate toxicity (Dawson et al., 1991) can increase neuronal survival. In addition, some of the toxic effects of NO may be linked to the activity of PKC (Maiese et al., 1993b,c) . PKC ac tivity can regulate the release of glutamate (Lu et al., 1993) during ischemia, and down-regulation of PKC activity has been shown to protect neurons J Cereb Blood Flow Metab, Vol. 15, No. 3, 1995 against glutamate tOXICIty (Favaron et al., 1988) , anoxia (Maiese et al., 1993b) , and NO (Maiese et al., 1993b,c) .
The signal transduction pathways of PKC also may modulate the protective effects of peptide growth factors. Trophic factors are intriguing in their ability to offer protection from several toxic states such as anoxia (Maiese et al., 1993a) , KCN (Pauwels et al., 1989) , hypoglycemia (Cheng and Mattson, 1991) , and NO (Maiese et al., 1993a ). Yet, the PKC pathway appears to also play a role in the cellular mechanisms regulated by growth factors. FGF requires the activity of PKC for immediate early gene induction (Bhat et al., 1992) and for mi togenesis of umbilical vein endothelial cells (Patte and Blanquet, 1992) . EGF is dependent upon PKC activity for corneal endothelial wound repair (Joyce and Meklir, 1992) , the maintenance of neuronal cells in culture (Abe et al., 1992) , and regulating intracellular pH (Li et al., 1991) . We therefore ex amined whether the protective mechanisms of the peptide growth factors bFGF and EGF were depen dent upon the modulation of PKC during anoxia and NO toxicity.
Inhibition of PKC activity is protective during several models of ischemic injury, including anoxia (Maiese et al., 1993b) , NO exposure (Maiese et al., 1993b,c) , glutamate toxicity (Favaron et al., 1988) , and animal models of global ischemia (Hara et al., 1990) . In contrast to these studies, the down regulation of PKC activity with PMA (1 f..L M) and the combined application of either bFGF or EGF reduced the protective effects of the growth factors during anoxia and NO exposure. This reduction in neuronal survival during the combined application of growth factors and the down-regulation of PKC activity also was present with the pharmacologic inhibition of PKC activity. Neuronal survival was decreased with growth factor application during treatment with H-7 00 f..L M). At this dose, H-7 is a selective inhibitor of PKC activity (K; = 6.0 f..L M), but also inhibits protein kinase A (PKA) (K; = 3.00 f..L M), and the cGMP-dependent protein kinase (K; = 5.80 f..L M) Kawamoto and Hidaka, 1984) . Administration of the agent H-8, an inhibitor of PKC activity (K; = 15 f..L M), PKA ac tivity (K; = 1.2 f..L M), and cGMP-dependent protein kinase activity (K; = 0.48 f..L M), also yielded similar results by reducing the protective effects of bFGF and EGF during anoxia and SNP administration. Thus, the loss of growth factor protection during H-7 and H-8 administration may initially appear to be a result of inhibition of activity of PKC, PKA, or the cGMP-dependent protein kinase. Yet, we have previously demonstrated that neuroprotection by both H-7 and H-8 during anoxia and NO adminis tration is linked to the capacity to inhibit the activ ity of PKC and not to the inhibition of PKA activity or to the inhibition of cGMP-dependent kinase ac tivity (Maiese et aI., 1993b) . Furthermore, the re duction in growth factor "efficacy" during PKC down-regulation with chronic PMA administration further supports the premise that modulation of PKC activity plays a dominant role in the neuropro tective effects of the peptide growth factors.
Although the protective effects of the individual peptide growth factors are reduced during inhibition of PKC activity, combined application of bFGF and EGF during inhibition of PKC activity also does not significantly improve neuronal survival. These re sults suggest that when administered together, the trophic factors, bFGF and EGF, may have reduced protective capabilities. For example, in rat astro cytes, bFGF functions to inhibit the trophic effects of EGF (Huff and Schreier, 1990) . In addition, bFGF reduces the affinity of EGF for its receptor in fibroblast cultures (Maher, 1993) .
In contrast to the reduction in neuronal survival observed with the combined inhibition of PKC ac tivity and administration of growth factors, activa tion of PKC completely eliminated the protective effects of bFGF and EGF during anoxia and NO administration. Except for the modest improvement in neuronal survival in the experimental paradigms with PKC activation and administration of both bFGF and EGF, neuronal survival during PKC ac tivation and growth factor administration did not differ significantly from the untreated control cul tures exposed to anoxia or NO. These results are consistent with previous studies that demonstrate that activation of PKC in both normoxic cultures and anoxic cultures results in cell death (Maiese et aI., 1993b,c) and that PKC activation is toxic to cortical neurons (Mattson, 1991) and hippocampal neurons (Mattson et aI., 1988) . It appears that "ex cessive" stimulation of PKC activity, such as with the application of PMA (100 nM), appears to com pletely negate the neuroprotective capacity of the growth factors.
Because PKC activation can modify the extent of neurodegeneration, our work suggests that peptide growth factors may protect during anoxia and NO toxicity by regulating the extent of PKC activation. Although individually protective during anoxia, the trophic factors, bFGF and EGF, and inhibitors of PKC activity decrease neuronal survival when ad ministered together, suggesting that some of the protective effects of growth factors may require a minimum level of PKC activation. Yet, one could speculate that once this "threshold level" of PKC activation is exceeded during an ischemic event, the combination of the trophic factors and PKC activa tion is no longer protective to neurons. For exam ple, activation of PKC by PMA (100 nM) adversely affected neuronal survival despite the presence of the peptide growth factors. It is possible that "ex cessive" or prolonged PKC activation can directly inhibit the neuroprotective effects of the peptide growth factors because PKC activation has been shown in cortical cultures to inhibit the trophic ac tions of bFGF and EGF (Morrison et aI., 1988) . Alternatively, acute PKC activation may be over whelming the protective ability of bFGF and EGF by enhancing calcium influx via N-methyl-D aspartate receptors Huang, 1991, 1992) , promoting NOS activity (Nakane et aI., 1991) , and increasing the production of NO (Severn et aI., 1992) . Thus, the growth factors may require some PKC activation, but if this level exceeds a thresh old, such as with a PMA dose of 100 nM, then the subsequent PKC activation may reverse the PKC dependent protective mechanisms and result in NO release and neurodegeneration.
It is important to note that the peptide growth factors bFGF and EGF appear to employ other mechanisms in addition to PKC for their protective effects. Inhibition of PKC activity with H-7 or H-8 was protective �4 h following exposure to SNP. In contrast, bFGF and EGF increased neuronal sur vival only when administered ;,:2 h before NO ex posure. Our results suggest that modulation of PKC activity may be a necessary prerequisite for protec tion against anoxia and NO toxicity by the peptide growth factors bFGF and EGF. Yet, additional sig nal transduction pathways downstream from the regulation of PKC activity may be required by the growth factors. For example, both PKA and cGMP dependent protein kinase have been implicated in the pathogenesis of NO toxicity (Maiese et aI., 1993b) . Basic FGF can regulate cAMP levels (Oury et al., 1992) and requires cAMP for mitogenic ac tivity (Chen et aI., 1991; Logan and Logan, 1991) . In addition, EGF can modulate both cAMP and cGMP levels in some cell systems (Miyazaki et aI., 1992; Nair et aI., 1993) . Cellular calcium, either ex ternal or internal, may also play a pivotal role in modulating the protective mechanisms of trophic factor protection. Several growth factors, including bFGF, have been shown to modulate cellular cal cium flux (Mattson et aI., 1989; Cheng and Mattson, 1994) and calcium is required for activation of the constituent form of NOS (Nakane et aI., 1991; Schmidt et aI., 1992; Maiese et aI., 1994b) .
With an incidence of 500,000 new strokes per year in the United States alone (Heart and Stroke Facts, 1991), cerebrovascular disease is considered to be a significant cause of death and disability around the world. Yet, it is now evident that sub sequent neuronal death following a stroke may be preventable. Recently, PKC and NO have been linked to anoxic neuronal cell death (Maiese et al., 1993b,c) . In addition, the peptide growth factors bFGF and EGF have been shown to be protective against anoxia and NO toxicity (Maiese et aI., 1993a) . We now provide evidence that the mecha nism of protection by these peptide growth factors may ultimately involve the PKC pathway. By iden tifying the specific mechanisms of protection of trophic factors against the cellular mediators of ischemic neurodegeneration, such as PKC and NO, one may ultimately direct therapy for the manage ment of stroke.
